340 related articles for article (PubMed ID: 22710101)
41. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
42. Invasion of the corticotrophs.
Mayberg MR
J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
[No Abstract] [Full Text] [Related]
43. Cushing Disease: Medical and Surgical Considerations.
Bray DP; Rindler RS; Dawoud RA; Boucher AB; Oyesiku NM
Otolaryngol Clin North Am; 2022 Apr; 55(2):315-329. PubMed ID: 35256173
[TBL] [Abstract][Full Text] [Related]
44. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
[TBL] [Abstract][Full Text] [Related]
45. Angio-oedema after trans-sphenoidal surgery in a patient with Cushing's disease.
Okan G; Muhammedrezai S; Vural P
Allergol Immunopathol (Madr); 2011; 39(1):52-3. PubMed ID: 20655139
[No Abstract] [Full Text] [Related]
46. Paediatric Cushing's disease: long-term outcome and predictors of recurrence.
Savage MO; Ferrigno R
Front Endocrinol (Lausanne); 2024; 15():1345174. PubMed ID: 38318299
[TBL] [Abstract][Full Text] [Related]
47. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
48. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
[TBL] [Abstract][Full Text] [Related]
49. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
[TBL] [Abstract][Full Text] [Related]
50. Rare case of Cushing's disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk.
Mendola M; Dolci A; Piscopello L; Tomei G; Bauer D; Corbetta S; Ambrosi B
Hormones (Athens); 2014; 13(4):574-8. PubMed ID: 25402386
[TBL] [Abstract][Full Text] [Related]
51. Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.
Braun LT; Rubinstein G; Zopp S; Vogel F; Schmid-Tannwald C; Escudero MP; Honegger J; Ladurner R; Reincke M
Endocrine; 2020 Nov; 70(2):218-231. PubMed ID: 32743767
[TBL] [Abstract][Full Text] [Related]
52. Triple jeopardy in the pituitary.
Goh KP; Lee HY; Rajasoorya RC
Pituitary; 2008; 11(3):331-6. PubMed ID: 18058238
[TBL] [Abstract][Full Text] [Related]
53. HOW I DO IT: Cushing's disease-selective adenomectomy via an endoscopic transsphenoidal approach.
Phillips N; Nix P; De Santos M
Acta Neurochir (Wien); 2024 Jun; 166(1):252. PubMed ID: 38842720
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes of children treated for Cushing's disease: a single center experience.
Yordanova G; Martin L; Afshar F; Sabin I; Alusi G; Plowman NP; Riddoch F; Evanson J; Matson M; Grossman AB; Akker SA; Monson JP; Drake WM; Savage MO; Storr HL
Pituitary; 2016 Dec; 19(6):612-624. PubMed ID: 27678103
[TBL] [Abstract][Full Text] [Related]
55. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
56. Update on radiation therapy in patients with Cushing's disease.
Tritos NA; Biller BM
Pituitary; 2015 Apr; 18(2):263-8. PubMed ID: 25359445
[TBL] [Abstract][Full Text] [Related]
57. Pituicytoma and Cushing's Disease in a 7-Year-Old Girl: A Mere Coincidence?
Cambiaso P; Amodio D; Procaccini E; Longo D; Galassi S; Camassei FD; Cappa M
Pediatrics; 2015 Dec; 136(6):e1632-6. PubMed ID: 26553184
[TBL] [Abstract][Full Text] [Related]
58. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
59. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Takeshita A; Inoshita N; Taguchi M; Okuda C; Fukuhara N; Oyama K; Ohashi K; Sano T; Takeuchi Y; Yamada S
Eur J Endocrinol; 2009 Oct; 161(4):553-9. PubMed ID: 19589911
[TBL] [Abstract][Full Text] [Related]
60. Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.
Yamamoto M; Nakao T; Ogawa W; Fukuoka H
Front Endocrinol (Lausanne); 2021; 12():650791. PubMed ID: 34220707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
